LMND Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||
net income | -42,400,000 | -61,500,000 | -67,200,000 | -65,800,000 | -63,700,000 | -91,400,000 | -67,900,000 | -74,800,000 | -70,300,000 | -66,400,000 | -55,600,000 | -49,000,000 | -33,900,000 | -30,900,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||
depreciation and amortization | 4,800,000 | 5,000,000 | 5,100,000 | 5,100,000 | ||||||||||
stock-based compensation | 14,300,000 | 15,400,000 | 14,800,000 | 15,400,000 | 15,700,000 | 15,600,000 | 13,900,000 | 14,100,000 | 13,400,000 | 12,700,000 | 11,900,000 | 6,100,000 | 3,300,000 | 2,700,000 |
amortization of premium (discount) on bonds | ||||||||||||||
benefit from bad debt | 2,100,000 | 2,100,000 | 1,600,000 | 2,300,000 | 2,300,000 | 2,800,000 | 1,600,000 | 2,000,000 | ||||||
asset impairment charge | 0 | |||||||||||||
changes in operating assets and liabilities: | ||||||||||||||
premium receivable | -900,000 | -27,500,000 | -14,400,000 | -7,700,000 | 6,000,000 | -25,600,000 | -13,600,000 | -10,600,000 | -300,000 | -22,500,000 | -11,100,000 | -13,300,000 | -4,100,000 | -18,500,000 |
reinsurance recoverable | 6,200,000 | 19,800,000 | -10,700,000 | 3,100,000 | -20,400,000 | -11,600,000 | 2,100,000 | -22,700,000 | -19,000,000 | -6,100,000 | 1,100,000 | -16,800,000 | -6,800,000 | -16,000,000 |
prepaid reinsurance premium | 1,300,000 | -31,000,000 | -6,800,000 | 4,700,000 | 17,200,000 | -12,800,000 | -12,200,000 | -7,100,000 | 600,000 | -29,900,000 | -15,900,000 | -13,100,000 | -5,100,000 | -86,200,000 |
deferred acquisition costs | -700,000 | -1,500,000 | 600,000 | -200,000 | -700,000 | -500,000 | -200,000 | -1,100,000 | -800,000 | -600,000 | -200,000 | -800,000 | ||
other assets | 3,900,000 | -200,000 | 4,500,000 | 700,000 | -1,900,000 | -4,800,000 | 3,900,000 | -4,200,000 | -23,600,000 | -13,500,000 | 100,000 | -1,600,000 | -600,000 | -7,900,000 |
unpaid losses and loss adjustment expenses | ||||||||||||||
unearned premium | -1,900,000 | 39,700,000 | 18,100,000 | 9,800,000 | -6,400,000 | 37,600,000 | 19,200,000 | 14,700,000 | 4,500,000 | 37,200,000 | 22,500,000 | 19,700,000 | 8,500,000 | 28,400,000 |
trade payables | -2,100,000 | 2,000,000 | -1,200,000 | 800,000 | -400,000 | -600,000 | -1,300,000 | 1,600,000 | -2,000,000 | 1,700,000 | 300,000 | -400,000 | 400,000 | 200,000 |
funds held for reinsurance treaties | -2,300,000 | 1,800,000 | 200,000 | -6,900,000 | 4,300,000 | 12,500,000 | 11,000,000 | 5,100,000 | 6,000,000 | 19,500,000 | 11,600,000 | 3,900,000 | 9,700,000 | |
deferred ceding commission | ||||||||||||||
ceded premium payable | -13,100,000 | 17,100,000 | -1,700,000 | 2,500,000 | -6,600,000 | -8,100,000 | -13,800,000 | 16,100,000 | -6,100,000 | 6,800,000 | 2,700,000 | 2,300,000 | ||
other liabilities and accrued expenses | 6,500,000 | 13,100,000 | -5,200,000 | 600,000 | -5,700,000 | 4,500,000 | -4,700,000 | 10,800,000 | 21,900,000 | 7,300,000 | 8,200,000 | 1,200,000 | ||
net cash from operating activities | -16,100,000 | -6,300,000 | -50,300,000 | -46,400,000 | -28,600,000 | -54,700,000 | -40,200,000 | -39,500,000 | -49,900,000 | -38,200,000 | -16,200,000 | -40,300,000 | -20,700,000 | -35,700,000 |
cash flows from investing activities: | ||||||||||||||
acquisition of business, net of cash acquired | 0 | |||||||||||||
proceeds from short-term investments sold or matured | 28,300,000 | 52,000,000 | 26,600,000 | 36,600,000 | 74,500,000 | 68,500,000 | 36,800,000 | 44,700,000 | 15,000,000 | 15,000,000 | ||||
proceeds from bonds sold or matured | 49,600,000 | 84,000,000 | 109,100,000 | 106,900,000 | 48,000,000 | 36,300,000 | 44,500,000 | 9,200,000 | 19,300,000 | 100,000 | 0 | |||
cost of short-term investments acquired | 0 | -19,300,000 | -29,000,000 | -23,200,000 | -18,400,000 | -61,000,000 | -39,400,000 | -17,900,000 | -23,300,000 | 0 | 0 | |||
cost of bonds acquired | -34,900,000 | -70,800,000 | -115,700,000 | -102,300,000 | -14,000,000 | -59,100,000 | -31,200,000 | -29,100,000 | -11,900,000 | -635,500,000 | 0 | 0 | ||
purchases of property and equipment | -2,400,000 | -2,200,000 | -1,900,000 | -2,700,000 | -2,600,000 | -2,900,000 | -1,800,000 | -2,800,000 | -2,000,000 | -2,700,000 | -2,700,000 | -2,000,000 | -1,300,000 | |
net cash from investing activities | 40,600,000 | 43,700,000 | -10,900,000 | 15,300,000 | 87,500,000 | 80,600,000 | 8,900,000 | 4,100,000 | 2,300,000 | -737,800,000 | -67,300,000 | -2,000,000 | 13,800,000 | 13,800,000 |
cash flows from financing activities: | ||||||||||||||
proceeds from borrowings under financing agreement | 9,800,000 | |||||||||||||
payment on borrowings under financing agreement | ||||||||||||||
proceeds from initial public offering and follow-on offering, net of underwriting discounts and commissions and offering costs | ||||||||||||||
proceeds from stock exercises | 0 | 200,000 | 200,000 | 100,000 | 300,000 | 2,300,000 | 400,000 | 600,000 | 600,000 | 900,000 | 1,700,000 | 6,100,000 | 1,500,000 | 200,000 |
net cash from financing activities | 7,200,000 | 7,900,000 | 200,000 | 100,000 | 300,000 | 2,300,000 | 400,000 | 600,000 | 600,000 | 900,000 | 1,700,000 | 646,400,000 | 1,500,000 | 338,200,000 |
effect of exchange rate changes on cash, cash equivalents and restricted cash | -1,000,000 | 0 | -700,000 | 2,300,000 | -2,800,000 | -2,000,000 | 2,000,000 | -200,000 | -800,000 | 1,100,000 | 600,000 | |||
net increase in cash, cash equivalents and restricted cash | -35,400,000 | -35,600,000 | -49,000,000 | -773,100,000 | -82,000,000 | 603,300,000 | -4,300,000 | 316,900,000 | ||||||
cash, cash equivalents and restricted cash at beginning of year | ||||||||||||||
cash, cash equivalents and restricted cash at end of year | ||||||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||
cash paid for income taxes | 100,000 | 300,000 | 100,000 | 200,000 | 0 | 700,000 | 1,600,000 | 1,100,000 | 1,100,000 | 1,000,000 | 500,000 | 600,000 | 500,000 | 300,000 |
cash paid for interest expense on borrowings under financing agreement | 200,000 | |||||||||||||
non-cash transactions: | ||||||||||||||
warrants assumed from acquisition of metromile | -500,000 | |||||||||||||
amortization of discount on bonds | 200,000 | 1,300,000 | 2,100,000 | 2,500,000 | -2,700,000 | 0 | -100,000 | |||||||
unpaid loss and loss adjustment expense | -500,000 | 10,400,000 | -11,000,000 | 21,500,000 | 15,300,000 | 9,700,000 | 9,300,000 | 2,500,000 | 15,900,000 | 4,400,000 | ||||
deferred ceding commissions | -2,500,000 | 2,100,000 | -200,000 | 900,000 | 3,300,000 | 2,300,000 | 6,000,000 | 4,100,000 | 3,600,000 | |||||
payments on borrowings under financing agreement | ||||||||||||||
net decrease in cash, cash equivalents and restricted cash | 44,300,000 | -61,000,000 | -31,700,000 | |||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 0 | 286,500,000 | 0 | 0 | 270,600,000 | 0 | 0 | 571,400,000 | 0 | ||||
cash, cash equivalents and restricted cash at end of period | 44,300,000 | -61,000,000 | 254,800,000 | 25,400,000 | -35,400,000 | 235,000,000 | -773,100,000 | -82,000,000 | 1,174,700,000 | 316,900,000 | ||||
common shares contribution to lemonade foundation | ||||||||||||||
unrealized loss on money market funds | ||||||||||||||
proceeds from release of shares upon repayment | 0 | 0 | ||||||||||||
depreciation | 3,700,000 | 1,600,000 | 1,500,000 | 1,200,000 | 800,000 | 800,000 | 900,000 | 600,000 | 400,000 | |||||
proceeds from follow-on offering, net of underwriting discounts and commissions and offering costs | 0 | 640,300,000 | ||||||||||||
effect of exchange rate changes on cash and cash equivalents | -800,000 | |||||||||||||
purchases of intangible assets | ||||||||||||||
issuance of preferred stock | ||||||||||||||
benefit from bad debts | 1,500,000 | 1,400,000 | 900,000 | |||||||||||
common shares contribution to the lemonade foundation | ||||||||||||||
proceeds from initial public offering and follow-on offering, net of underwritingdiscounts and commissions and offering costs | ||||||||||||||
change in fair value of warrant liability | ||||||||||||||
proceeds from initial public offering, net of underwriting discount and offering costs | ||||||||||||||
noncash interest | ||||||||||||||
common share contribution to the lemonade foundation | 0 | |||||||||||||
proceeds from initial public offering, net of underwriting discounts and commissions and offering costs | ||||||||||||||
purchases of property plant and equipment |